Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2020-10-01
Edice:Pharmaceuticals
Témata:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
On-line přístup:https://www.mdpi.com/1424-8247/13/10/324
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky